80 related articles for article (PubMed ID: 1300912)
1. Rheological leukocyte indexes in diabetes mellitus type II.
Perego MA; Danese C; Volpe MS; Zavattaro E; Calisi L
Ann Cardiol Angeiol (Paris); 1992 Dec; 41(10):A75-80. PubMed ID: 1300912
[TBL] [Abstract][Full Text] [Related]
2. Polymorphonuclear leukocyte: rheology, metabolism and integrin pattern in vascular atherosclerotic disease and in type 2 diabetes mellitus.
Caimi G; Lo Presti R; Montana M; Carollo C; Amodeo G; Romano A; Canino B
Clin Hemorheol Microcirc; 2004; 30(3-4):229-35. PubMed ID: 15258348
[TBL] [Abstract][Full Text] [Related]
3. [Evaluation of various hemorheologic parameters in diabetes mellitus].
Cella A; Bianchi E; Reali GL; Piana A; Armani U
Boll Soc Ital Biol Sper; 1990 Apr; 66(4):335-42. PubMed ID: 2390223
[TBL] [Abstract][Full Text] [Related]
4. [Modification of hemorheological parameters in microvascular complications of diabetes].
Bauduceau B; Renaudeau C; Mayaudon H; Hélie C; Ducorps M; Sonnet E; Yvert JP
Diabete Metab; 1995 Jun; 21(3):188-93. PubMed ID: 7556810
[TBL] [Abstract][Full Text] [Related]
5. Nicotinamide effects oxidative burst activity of neutrophils in patients with poorly controlled type 2 diabetes mellitus.
Osar Z; Samanci T; Demirel GY; Damci T; Ilkova H
Exp Diabesity Res; 2004; 5(2):155-62. PubMed ID: 15203886
[TBL] [Abstract][Full Text] [Related]
6. Rheological changes in diabetic microangiopathy.
Negrean V; Suciu I; Sâmpelean D; Cozma A
Rom J Intern Med; 2004; 42(2):407-13. PubMed ID: 15529630
[TBL] [Abstract][Full Text] [Related]
7. [Relationship between the level of plasma D-dimer and diabetic microangiopathy].
Long ZF; Qu GY; Xu M
Hunan Yi Ke Da Xue Xue Bao; 2001 Oct; 26(5):434-6. PubMed ID: 12536492
[TBL] [Abstract][Full Text] [Related]
8. [Diabetes and hemorheology].
Attali JR; Valensi P
Diabete Metab; 1990; 16(1):1-6. PubMed ID: 2185052
[TBL] [Abstract][Full Text] [Related]
9. Leukocyte flow properties, polymorphonuclear membrane fluidity, and cytosolic Ca2+ content in subjects with vascular atherosclerotic disease with and without noninsulin-dependent diabetes mellitus.
Caimi G; Canino B; Ferrara F; Montana M; Meli F; Catania A; Lo presti R
Angiology; 1996 Aug; 47(8):757-63. PubMed ID: 8712478
[TBL] [Abstract][Full Text] [Related]
10. [Blood and plasma viscosity and the distance of intermittent claudication in patients with type II diabetes and thrombophlebitis].
Turczyński B; Sroczyński J; Matyszczyk B; Szczesny S; Strugala M
Wiad Lek; 1990 Jun; 43(11):483-8. PubMed ID: 2219912
[TBL] [Abstract][Full Text] [Related]
11. Blood viscosity and erythrocyte filterability: their evaluation in diabetes mellitus.
Caimi G
Horm Metab Res; 1983 Oct; 15(10):467-70. PubMed ID: 6642407
[TBL] [Abstract][Full Text] [Related]
12. Interaction between serum amyloid A and leukocytes - a possible role in the progression of vascular complications in diabetes.
Hatanaka E; Monteagudo PT; Marrocos MS; Campa A
Immunol Lett; 2007 Feb; 108(2):160-6. PubMed ID: 17267050
[TBL] [Abstract][Full Text] [Related]
13. The relationship between levels of alpha1-acid glycoprotein and metabolic parameters of diabetes mellitus.
Akbay E; Yetkin I; Ersoy R; Kulaksizoğlu S; Törüner F; Arslan M
Diabetes Nutr Metab; 2004 Dec; 17(6):331-5. PubMed ID: 15887626
[TBL] [Abstract][Full Text] [Related]
14. [Prevalence of diabetes, antidiabetic treatment and chronic diabetic complications reported by general practitioners].
Fabian W; Majkowska L; Stefański A; Moleda P
Przegl Lek; 2005; 62(4):201-5. PubMed ID: 16229234
[TBL] [Abstract][Full Text] [Related]
15. Polymorphonuclear leukocyte membrane fluidity and cytosolic Ca2+ concentration in subjects with vascular atherosclerotic disease subdivided according to its extent.
Lo Presti R; Tozzi Ciancarelli MG; Canino B; Carollo C; Lucido D; Amodeo G; Romano A; Caimi G
Clin Hemorheol Microcirc; 2006; 35(1-2):199-201. PubMed ID: 16899927
[TBL] [Abstract][Full Text] [Related]
16. Polymorphonuclear leukocyte integrin profile in diabetes mellitus.
Caimi G; Montana M; Citarrella R; Porretto F; Catania A; Lo Presti R
Clin Hemorheol Microcirc; 2002; 27(2):83-9. PubMed ID: 12237478
[TBL] [Abstract][Full Text] [Related]
17. Fibrinolytic measurements in type 2 diabetic patients with acute cerebral infarction.
Mansfield MW; Catto AJ; Carter AM; Grant PJ
Diabet Med; 1998 Nov; 15(11):953-7. PubMed ID: 9827850
[TBL] [Abstract][Full Text] [Related]
18. [Determination of N-acetyl-glucosaminidase (NAG) in diabetic subjects].
Melosi A; Ricci F
Quad Sclavo Diagn; 1983 Mar; 19(1):113-20. PubMed ID: 6675040
[TBL] [Abstract][Full Text] [Related]
19. [Clinical analysis of serum endothelin in type 2 diabetic patients with vascular complications].
Fang YH; Zhang JP; Zhou SX; Zheng JF; Yu YW; Yan SG; Fan WK; Chen YS
Di Yi Jun Yi Da Xue Xue Bao; 2005 Aug; 25(8):1007-8, 1011. PubMed ID: 16109562
[TBL] [Abstract][Full Text] [Related]
20. Diabetes mellitus: its effect on the flow properties of blood.
Oughton J; Barnes AJ; Kohner EM
Horm Metab Res Suppl; 1981; 11():112-20. PubMed ID: 6797911
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
